Skip to main content
Signal8
Launch Terminal
Desai Neil profile photo

Neil Desai

CIK: 0001878692

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Whitehawk Therapeutics, Inc. logo
WHWK

Whitehawk Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    38K shares-
  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    Jun 12, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    40K shares-
  • Aadi Bioscience, Inc. logo
    AADI

    Aadi Bioscience, Inc.

    Sep 3, 2024
    Sale(S)
    Indirect
    40K shares at avg. $1.71$68K

1-3 of 3

About Desai Neil

Desai Neil (SEC CIK 0001878692) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK).

Signal8 holds 3 ownership filings by Desai Neil, all Form 4s, filed between Sep 5, 2024 and Jun 15, 2026. Those filings report 3 transactions, from Sep 3, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Desai Neil's filings is in MORRISTOWN, NJ.

Recent filings by Desai Neil

  • Jun 12, 2026: Grant or award of WHWK derivative securities (Form 4, code A).
  • Jun 12, 2025: Grant or award of WHWK derivative securities (Form 4, code A).
  • Sep 3, 2024: Open-market sale of AADI shares (Form 4, code S).

Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)

How to read Form 4 transaction codes